News/Risk management

A-IRB is overly prescriptive, say US banks

Several US banks would like to see a full internal models-based approach to regulatory capital. According to their response to the Advance Notice of Proposed Rulemaking (ANPR) on the implementation of the new Basel Capital Accord, the banks said the…

RMA signs up for OpVantage First database

The Risk Management Association (RMA) has signed up to use OpVantage's First (financial institutions risk scenario trend) database. OpVantage, a division of rating agency Fitch, provides operational risk software to the industry.

Fed's Ferguson defends US position on Basel

The US approach to regulatory capital is "perfectly consistent" with the spirit of the new risk management proposals from the Basel Committee, said Roger Ferguson, vice-chairman of the board of governors of the US Federal Reserve System, this week.

Strong global OTC growth continues

A surge in interest rate swaps drove a global increase in the over-the-counter derivatives market of 20% over the first half of this year, according to figures released today by the Bank for International Settlements (BIS).

CBOT chief again hits out at Eurex US

Chicago Board of Trade (CBOT) chairman Charles Carey urged the Commodity Futures Trading Commission to conduct a full and careful review of the application by Eurex to establish a US subsidiary yesterday. Carey’s comments are the latest in an ongoing…

US legislators question Basel II effectiveness

The Financial Services Committee of the US Congress said today it is not convinced that the current proposals under Basel II will be able to reflect modern risk management practices and eliminate regulatory arbitrage opportunities.

Lloyds TSB hires FSA risk regulator

Lloyds TSB, fined recently by the Financial Services Authority (FSA) for mis-selling investment products to retail investors, has responded by hiring the UK financial watchdog's top risk regulator.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here